Novartis AG (NYSE: NVS) announced Monday that it is adding to its immunomodulatory medicine portfolio with with an acquisition. What Happened Novartis said it's acquiring IFM Tre, a subsidiary of IFM ...

HOUSTON, Dec. 16, 2013 /PRNewswire/ — Freeport LNG Expansion, L.P. (Freeport LNG) and IFM Investors today announced that IFM Investors has entered into an agreement to invest approximately $1.3 ...

Novartis is handing over $310 million up front to acquire IFM Therapeutics’ inflammation-centered subsidiary, IFM Tre. The deal includes up to $1.265 billion in milestones and gives Novartis access to ...

IFM Investors Pty is in talks to raise about 1.6 billion Swiss francs ($2 billion) in debt to back its acquisition of Swiss data center operator Green Group AG, people with knowledge of the matter ...

Novartis has agreed to acquire a subsidiary of IFM Therapeutics for up to $1.575 billion, IFM said today, in a deal that will expand the pharma giant’s pipeline with one clinical and two pre-clinical ...

Australian investment manager IFM Investors will wind down its domestic private equity unit in coming years, citing a lack of scale to make it commercially viable and a focus on other global ...

Gift 5 articles to anyone you choose each month when you subscribe. IFM Investors has launched another attack on toll road group Atlas Arteria, declaring that its $2.9 billion purchase of the Chicago ...